Hypothyroidism: current state of the problem

The article presents the issues of epidemiology, classification, and clinic of hypothyroidism. The frequency of hypothyroidism increases significantly with age. The most common form is primary hypothyroidism, caused by a pathological process in the thyroid gland itself. Secondary hypothyroidism or tertiary hypothyroidism is caused by insufficient secretion of thyroid- stimulating hormone (TSH), or thyrotropin-releasing hormone. The article deals with the main causes of primary and secondary hypothyroidism. The most common cause of primary hypothyroidism is autoimmune thyroiditis, which can develop both separately and simultaneously with other autoimmune diseases, as part of polyglandular syndrome. Special attention should be paid to the change of thyroid status as a result of adverse side reactions when using a range of drugs. The questions about the mechanisms of thyroid insufficiency development as a result of unfavorable side reactions when using a number of drugs (lithium preparations, iodine-containing compounds, tyrosine kinase inhibitors, etc.) have been raised. Undiagnosed hypothyroidism is a risk factor for the progression of already existing cardiovascular diseases. The severity of clinical manifestations is determined by the severity of thyroid hormone deficiency. There are no significant clinical differences between the pronounced forms of primary and secondary hypothyroidism. Depending on the degree of lesion, secondary hypothyroidism may be complicated by other manifestations of hypothalamic-pituitary disorders, as well as the latter may include a decrease in the secretion of antidiuretic hormone at a certain stage of their development. Diagnostic difficulties are discussed, as hypothyroidism disrupts the functioning of most organs and systems of the body (musculoskeletal, cardiovascular, urinary, gastrointestinal, central and peripheral nervous systems) and can be masked by various diseases. The final diagnosis of hypothyroidism is clarified by a number of laboratory and instrumental studies. Substitution therapy with levothyroxine is used to treat hypothyroidism of any etiology.

1. Lindholm J., Laurberg P. Hypothyroidism and thyroid substitution: historical aspects. Journal of Thyroid Research. 2011;2011:809341. doi: 10.4061/2011/809341.

2. Roberts C.G., Ladenson P.W. Hypothyroidism. Lancet. 2004;363(9411):793– 803. doi: 10.1016/S0140-6736(04)15696-1.

3. Aoki Y., Belin R.M., Clickner R., Jeffries R., Phillips L., Mahaffey K.R. Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002). Thyroid. 2007;17(12):1211–1223. doi: 10.1089/thy.2006.0235.

4. Cooper D.S., Biondi B. Subclinical thyroid disease. Lancet. 2012;379(9821):1142–1154. doi: 10.1016/S0140-6736(11)60276-6.

5. Vanderpump M.P. The epidemiology of thyroid disease. Br Med Bull. 2011;99(1):39–51 doi: 10.1093/bmb/ldr030.

6. Sawin C.T., Castelli W.P., Hershman J.M., McNamara P., Bacharach P. The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med. 1985;145(8):1386–1388. doi: 10.1001/archinte.1985.00360080056006.

7. Bello F., Bakari A.G. Hypothyroidism in adults: A review and recent advances in management. Journal of Diabetes and Endocrinology. 2012;3(5):57–69. doi: 10.5897/jde11.017.

8. Park S.M., Chatterjee V.K. Genetics of congenital hypothyroidism. J Med Genet. 2005;42(5):379–389. doi: 10.1136/jmg.2004.024158.

9. Caturegli P., De Remigis A., Rose N.R. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13(4–5):391–397. doi: 10.1016/j.autrev.2014.01.007.

10. Effraimidis G., Wiersinga W.M. Mechanisms in endocrinology: autoimmune thyroid disease: old and new players. Eur J Endocrinol. 2014;170(6):241–252. doi: 10.1530/EJE-14-0047.

11. Park S., Jeon M.J., Song E., Oh H.S., Kim M., Kwon H., Kim T.Y. et al. Clinical features of early and late postoperative hypothyroidism after lobectomy. J Clin Endocrinol Metab. 2017;102(4):1317–1324. doi: 10.1210/jc.2016-3597.

12. Verloop H., Louwerens M., Schoones J.W., Kievit J., Smit J.W., Dekkers O.M. Risk of hypothyroidism following hemithyroidectomy: systematic review and meta-analysis of prognostic studies. J Clin Endocrinol Metab. 2012;97(7):2243–2255. doi: 10.1210/jc.2012-1063.

13. Tsyb A.F., Matveenko E.G., Nestaiko G.B., Gorobets V.F. Radiation associated hypothyroidism (Scientific review). Radiatsiya i risk = Radiation and risk. 1997;10:61–83. (In Russ.) Available at: http://radiation-and-risk.com/year1997/1/1894-4.

14. Yamada M., Mori M. Mechanisms related to the pathophysiology and management of central hypothyroidism. Nat Clin Pract Endocrinol Metab. 2008;4(12):683–694. doi: 10.1038/ncpendmet0995.

15. Grunenwald S., Caron, P. Central hypothyroidism in adults: better understanding for better care. Pituitary. 2015;18(1):169–175. doi: 10.1007/s11102-014-0559-8.

16. Rizzo L.F.L., Mana D.L., Serra H.A. Drug-induced hypothyroidism. Medicina (B Aires). 2017;77(5):394–404. Available at: http://www.medicinabuenosaires.com/PMID/29044016.pdf.

17. Brown R.L. Tyrosine kinase inhibitor-induced hypothyroidism: incidence, etiology, and management. Target Oncol. 2011;6(4):217–226. doi: 10.1007/s11523-011-0197-2.

18. Philippou G., Koutras D.A., Piperingos G., Souvatzoglou A., Moulopoulos S.D. The effect of iodide on serum thyroid hormone levels in normal persons, in hyperthyroid patients, and in hypothyroid patients on thyroxine replace-ment. Clin Endocrinol (Oxf ). 1992;36(6):573–578. doi: 10.1111/j.1365-2265.1992.tb02267.x.

19. Lee S.Y., Rhee C.M., Leung A.M., Braverman L.E., Brent G.A., Pearce E.N. A review: Radiographic iodinated contrast-induced thyroid dysfunction. J Clin Endocrinol Metab. 2015;100(2):376–383. doi: 10.1210/jc.2014-3292.

20. Laurberg P., Andersen S., Bülow Pedersen I., Carlé A. Hypothyroidism in the elderly: pathophysiology, diagnosis and treatment. Drugs Aging. 2005;22(1):23–38. doi: 10.2165/00002512-200522010-00002.

21. Kornelius E., Chiou J.Y., Yang Y.S., Peng C.H., Lai Y.R., Huang C.N. Iodinated contrast media increased the risk of thyroid dysfunction: A 6-year retrospective cohort study. J Clin Endocrinol Metab. 2015;100(9):3372–3379. doi: 10.1210/JC.2015-2329.

22. Mosher M.C. Amiodarone-induced hypothyroidism and other adverse effects. Dimens Crit Care Nurs. 2011;30(2):87–93. doi: 10.1097/DCC.0b013e3182052130.

23. Bartalena L., Bogazzi F., Chiovato L., Hubalewska-Dydejczyk A., Links T.P., Vanderpump M. 2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction. Eur Thyroid J. 2018;7(2):55–66. doi: 10.1159/000486957.

24. Mir S.A., Wani A.I., Masoodi S.R., Bashir M.I., Ahmad N. Lithium toxicity and myxedema crisis in an elderly patient. Indian J Endocrinol Metab. 2013;17(9):654–656. doi: 10.4103/2230-8210.123558.

25. Cooper D.S. Antithyroid drugs. N Engl J Med. 2005;352(9):905–917. doi: 10.1056/NEJMra042972.

26. Makita N., Iri T. Tyrosine kinase inhibitor-induced thyroid disorders: A review and hypothesis. Thyroid. 2013;23(2):151–159. doi: 10.1089/thy.2012.0456.

27. Boelaert K. Thyroid dysfunction in the elderly. Nat Rev Endocrinol. 2013;9(4):194–204. doi: 10.1038/nrendo.2013.30.

28. Li Y., Nishihara E., Kakudo K. Hashimoto’s thyroiditis: old concepts and new insights. Curr Opin Rheumatol. 2011;23(1):102–107. doi: 10.1097/BOR.0b013e328341378c.

29. Hall R., Scanlon M.F. Hypothyroidism: clinical features and complications. Clin Endocrinol Metab. 1979;8(1):29–38. doi: 10.1016/s0300-595x(79)80007-9.

30. Grais I.M., Sowers J.R. Thyroid and the heart. Am J Med. 2014;127(8):691–698. doi: 10.1016/j.amjmed.2014.03.009.

31. Faber J., Selmer C. Cardiovascular disease and thyroid function. Front Horm Res. 2014;43:45–56. doi: 10.1159/000360558.

32. Hernando V.U., Eliana M.S. Role of Thyroid Hormones in Different Aspects of Cardiovascular System. Endocrin Metab Synd. 2015;4(2):166. doi: 10.4172/2161-1017.1000166.

33. Artantas S., Gul U., Kilic A., Guler S. Skin findings in thyroid diseases. Eur J Intern Med. 2009;209(2):158–161. doi: 10.1016/j.ejim.2007.09.021.

34. Grunstein R.R., Sullivan C.E. Sleep apnea and hypothyroidism: mechanisms and management. Am J Med. 1988;85(6):775–779. doi: 10.1016/s0002-9343(88)80020-2.

35. Biondi B. Heart failure and thyroid dysfunction. European Journal of Endocrinology. 2012;167(5):609–618. doi: 10.1530/EJE-12-0627.

36. Kim B. Thyroid hormone as a determinant of energy expenditure and the basal metabolic rate. Thyroid. 2008;18(2):141–144. doi: 10.1089/thy.2007.0266.

37. Lu S., Guan Q., Liu Y., Wang H., Xu W., Li X., Fu Y., Gao L., Zhao J., Wang X. Role of extrathyroidal TSHR expression in adipocyte differentiation and its association with obesity. Lipids Health Dis. 2012;11(1):17. doi: 10.1186/1476-511X-11-17.

38. de Carvalho G.A., Fighera T.M. Effect of gastrointestinal disorders in autoimmune thyroid diseases. Transl Gastrointest Cancer. 2015;4(1):76–82. doi: 10.3978/j.issn.2224-4778.2014.07.03.

39. Völzke H., Robinson D.M., John U. Association between thyroid function and gallstone disease. World J Gastroenterol. 2005;11(35):5530–5534. doi: 10.3748/wjg.v11.i35.5530.

40. Kimmel M., Braun N., Alscher M.D. Influence of thyroid function on different kidney function tests. Kidney Blood Press Res. 2012;35(1):9–17. doi: 10.1159/000329354.

41. Rhee C.K. The Interaction Between Thyroid and Kidney Disease: An Overview of the Evidence. Curr Opin Endocrinol Diabetes Obes. 2016;23(5):407–415. doi: 10.1097/MED.0000000000000275.

42. Kulagina T.I., Koriakova N.V., Rodionova O.A., Vezikova N.N., Kannoeva I.I. Severe depression and rhabdomyolysis as “masks” of primary hypothyroidism: clinical cases. Al’manakh klinicheskoy meditsiny = Almanac of Clinical Medicine 2019;47(2):186–194. doi: 10.18786/2072-0505-2019-47-012.

43. De Sousa A., Shrivastava A. Neurocognition and hypothyroidism: Critical points. Ann Indian Psychiatry. 2017;1(2):118–119. doi: 10.4103/aip.aip_26_17.

44. Dugbartey A.T. Neurocognitive aspects of hypothyroidism. Arch Int Med 1998;158(13):1413–1418. doi: 10.1001/archinte.158.13.1413.

45. Esina M.M. System of reproduction in hypothyreosis. Arkhiv akusherstva i ginekologii im. V.F. Snegireva = V.F. Snegirev Archives of Obstetrics and Gynecology, Russian journal. 2017;4(2):77–83. (In Russ.) doi: 10.18821/2313-8726-2017-4-2-77-83.

46. Honbo K.S., van Herle A.J., Kellett K.A. Serum prolactin levels in untreated primary hypothyroidism. Am J Med. 1978;64(5):782–787. doi: 10.1016/0002-9343(78)90517-x.

47. Ben-Jonathan N., Hnasko R. Dopamine as a prolactin inhibitor. Endocrine Rewiews. 2001;22(6):724–763. doi: 10.1210/edrv.22.6.0451.

48. Collins A.B., Pawlak R. Prevalence of vitamin B-12 deficiency among patients with thyroid dysfunction. Asia Pac J Clin Nutr. 2016;25(2):221–226. doi: 10.6133/apjcn.2016.25.2.22.

49. Joshi A.S., Woolf P.D. Pituitary hyperplasia secondary to primary hypothyroidism: a case report and review of the literature. Pituitary. 2005;8(2):99–103. doi: 10.1007/s11102-005-3281-8.

50. Garber J.R., Cobin R.H., Gharib H., Hennessey J.V., Klein I., Mechanick J.I. et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(6):988–1028. doi: 10.4158/EP12280.GL.

51. O’Leary P.C., Feddema P.H., Michelangeli V.P., Leedman P.J., Chew G.T., Knuiman M. et al. Investigations of thyroid hormones and antibodies based on a community health survey: the Busselton thyroid study. Clin Endocrinol. 2006;64(1):97–104. doi: 10.1111/j.1365-2265.2005.02424.x.

52. Clarke N., Kabadi U.M. Optimizing treatment of hypothyroidism. Treat Endocrinol. 2004;3(4):217–221. doi: 10.2165/00024677-200403040-00003.

53. Hueston W.J. Treatment of hypothyroidism. Am Fam Physician. 2001;64(10):1717–1724. Available at: https://www.ncbi.nlm.nih.gov/pubmed/11759078.

54. Todd C.H. Management of thyroid disorders in primary care: challenges and controversies. Postgrad Med J. 2009;85(1010):655–659. doi: 10.1136/pgmj.2008.077701.

55. Gaitonde D.Y., Rowley K.D., Sweeney L.B. Hypothyroidism: An Update. Am Fam Physician. 2012;86(3):244–251. doi: 10.1080/20786204.2012.10874256.

56. Jonklaas J., Bianco A.C., Bauer A.J., Burman K.D., Cappola A.R., Celi F.S. et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014;24(12):1670–1751. doi: 10.1089/thy.2014.0028.

57. Liwanpo L., Hershman J.M. Conditions and drugs interfering with thyroxine absorption. Best Pract Res Clin Endocrinol Metab. 2009;23(6):781–792. doi: 10.1016/j.beem.2009.06.006.

58. Virili C., Antonelli A., Santaguida M.G., Benvenga S., Centanni M. Gastrointestinal Malabsorption of Thyroxine. Endocr Rev. 2019;40(1):118–136. doi: 10.1210/er.2018-00168.

59. Sawin C.T., Chopra D., Azizi F., Mannix J.E., Bacharach P. The aging thyroid. Increased prevalence of elevated serum thyrotropin levels in the elderly. JAMA. 1979;242(3):247–250. Available at: https://www.ncbi.nlm.nih.gov/pubmed/448912.

60. Centanni M., Gargano L., Canettieri G., Viceconti N., Franchi A., Delle Fave G., Annibale B. Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med. 2006;354(17):1787–1795. doi: 10.1056/NEJMoa043903.

61. Lahner E., Virili C., Santaguida M.G., Annibale B., Centanni M. Helicobacter pylori infection and drugs malabsorption. World J Gastroenterol. 2014;20(30):10331–10337. doi: 10.3748/wjg.v20.i30.10331.

62. Barbesino G. Drugs Affecting Thyroid Function. Thyroid. 2010;20(7):763–770. doi: 10.1089/thy.2010.1635.

63. McMillan M., Rotenberg K.S., Vora K., Sterman A.B., Thevathasan L., Ryan M.F. et al. Comorbidities, Concomitant Medications, and Diet as Factors Affecting Levothyroxine Therapy: Results of the CONTROL Surveillance Project. Drugs in R&D. 2016;16(1):53–68. doi: 10.1007/s40268-015-0116-6.

64. Lomer M.C., Parkes G.C., Sanderson J.D. Review article: lactose intolerance in clinical practice – myths and realities. Aliment Pharmacol Ther. 2008;27(2):93–103. doi: 10.1111/j.1365-2036.2007.03557.x.

65. Arafah B.M. Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med. 2001;344(23):1743–1749. doi: 10.1056/NEJM200106073442302.

66. Muñoz-Torres M., Varsavsky M., Alonso G. Lactose intolerance revealed by severe resistance to treatment with levothyroxine. Thyroid. 2006;16(11):1171–1173. doi: 10.1089/thy.2006.16.1171.

67. Taylor J., Williams B.O., Frater J., Stott D.J., Connell J. Twice-weekly dosing for thyroxine replacement in elderly patients with primary hypothyroidism. J Int Med Res. 1994;22(5):273–277. doi: 10.1177/030006059402200504.